Skip to main content
SpringerLink
Log in

Breast Cancer

  • Chapter
  • First Online:
Lymphedema

  • 2831 Accesses

Abstract

In Western countries, the most common cause of lymphedema is treatment for breast cancer. Lymphedema can present in the arm, hand, and/or trunk region. For the majority of women who develop lymphedema, physical presentation remains mild but can be still very distressing. Surveillance and tailored education depending on risk of lymphedema are required for early detection. For those who develop any swelling, early intervention appears critical.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

Highlighted References

  1. Sierla R, Lee TS, Black D, Kilbreath SL. Lymphedema following breast cancer: regions affected, severity of symptoms, and benefits of treatment from the patients’ perspective. Clin J Oncol Nurs. 2013;17(3):325–31.

    Article  PubMed  Google Scholar 

  2. Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27(3):390–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36.

    Article  CAS  PubMed  Google Scholar 

  4. Dylke ES, Schembri GP, Bailey DL, Bailey E, Ward LC, Refshauge K, et al. Diagnosis of upper limb lymphoedema: development of an evidence-based approach. Acta Oncol. 2016;55:1477. doi:10.1080/0284186X.2016.1191668.

    Article  CAS  PubMed  Google Scholar 

  5. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.

    Article  PubMed  Google Scholar 

References

  1. Oliveri JM, Day JM, Alfano CM, Herndon JE 2nd, Katz ML, Bittoni MA, et al. Arm/hand swelling and perceived functioning among breast cancer survivors 12 years post-diagnosis: CALGB 79804. J Cancer Surviv. 2008;2(4):233–42.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536–42.

    Article  PubMed  Google Scholar 

  3. Kilbreath SL, Lee MJ, Refshauge KM, Beith JM, Ward LC, Simpson JM, et al. Transient swelling versus lymphoedema in the first year following surgery for breast cancer. Support Care Cancer. 2013;21(8):2207–15.

    Article  PubMed  Google Scholar 

  4. Ohsumi S, Shimozuma K, Ohashi Y, Takeuchi A, Suemasu K, Kuranami M, et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: the National Surgical Adjuvant Study of breast cancer 02. Oncology. 2012;82(3):131–8.

    Article  CAS  PubMed  Google Scholar 

  5. Lee MJ, Beith J, Ward L, Kilbreath S. Lymphedema following taxane-based chemotherapy in women with early breast cancer. Lymphat Res Biol. 2014;12(4):282–8.

    Article  CAS  PubMed  Google Scholar 

  6. Cormier J, Xing Y, Zaniletti I, Askew R, Stewart B, Armer J. Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology. 2009;42(4):161–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Stanton AW, Mellor RH, Cook GJ, Svensson WE, Peters AM, Levick JR, et al. Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. Lymphat Res Biol. 2003;1(2):121–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Svensson B, Dylke E, Ward L, Kilbreath S. Segmental impedance thresholds for early detection of unilateral upperlimb swelling. Lymphat Res Biol. 2015;13(4):253–9.

    Article  CAS  PubMed  Google Scholar 

  9. Dylke ES, Ward LC, Meerkin JD, Nery L, Kilbreath SL. Tissue composition changes and secondary lymphedema. Lymphat Res Biol. 2013;11(4):211–8.

    Article  CAS  PubMed  Google Scholar 

  10. Brorson H, Ohlin K, Olsson G, Karlsson MK. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol. 2009;7(1):3–10.

    Article  PubMed  Google Scholar 

  11. Brorson H, Ohlin K, Olsson G, Nilsson M. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat Res Biol. 2006;4(4):199–210.

    Article  PubMed  Google Scholar 

  12. Rockson SG. Lymphedema. Am J Med. 2001;110(4):288–95.

    Article  CAS  PubMed  Google Scholar 

  13. Bar Ad V, Cheville A, Solin LJ, Dutta P, Both S, Harris EE. Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2010;76(1):85–90.

    Article  PubMed  Google Scholar 

  14. Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691–8.

    Article  PubMed  Google Scholar 

  15. Cheng CT, Deitch JM, Haines IE, Porter DJ, Kilbreath SL. Do medical procedures in the arm increase the risk of lymphoedema after axillary surgery? A review. ANZ J Surg. 2014;84(7–8):510–4.

    Article  PubMed  Google Scholar 

  16. Kilbreath SL, Ward LC, Lane K, McNeely M, Dylke ES, Refshauge KM, et al. Effect of air travel on lymphedema risk in women with history of breast cancer. Breast Cancer Res Treat. 2010;120:649.

    Article  PubMed  Google Scholar 

  17. Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304(24):2699–705.

    Article  CAS  PubMed  Google Scholar 

  18. Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Lee M, Simpson JM, et al. Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial. Breast Cancer Res Treat. 2012;133(2):667–76.

    Article  PubMed  Google Scholar 

  19. Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl):2191–200.

    Article  PubMed  Google Scholar 

  20. Dylke ES, Kilbreath S. Current rehabilitation processes do not prevent long-term impairments after treatment for breast cancer in Australia. Aust Fam Physician. 2015;44(6):405–9.

    PubMed  Google Scholar 

  21. Sun F, Skolny MN, Swaroop MN, Rawal B, Catalano PJ, Brunelle CL, et al. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat. 2016;157(2):229–40.

    Article  CAS  PubMed  Google Scholar 

  22. Kilbreath SL, Refshauge KM, Ward LC, Kastanias K, Yee J, Koelmeyer LA, et al. Factors affecting the preoperative and postoperative extracellular fluid in the arm on the side of breast cancer: a cohort study. Lymphat Res Biol. 2013b;11(2):66–71.

    Article  PubMed  Google Scholar 

  23. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.

    Article  PubMed  Google Scholar 

  24. Dylke ES, Yee J, Ward LC, Foroughi N, Kilbreath SL. Normative volume difference between the dominant and nondominant upper limbs in healthy older women. Lymphat Res Biol. 2012;10(4):182–8.

    Article  CAS  PubMed  Google Scholar 

  25. Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2–11.

    CAS  PubMed  Google Scholar 

  26. Stuiver MM, ten Tusscher MR, Agasi-Idenburg CS, Lucas C, Aaronson NK, Bossuyt PM. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy. Cochrane Database Syst Rev. 2015;(2):Cd009765.

    Google Scholar 

  27. Gebruers N, Tjalma WA. Clinical feasibility of axillary reverse mapping and its influence on breast cancer related lymphedema: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;200:117–22.

    Article  PubMed  Google Scholar 

  28. Boccardo F, Casabona F, De Cian F, Friedman D, Murelli F, Puglisi M, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery. 2014;34(6):421–4.

    Article  PubMed  Google Scholar 

  29. Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W. Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review. Arch Phys Med Rehabil. 2015;96(6):1131–9.

    Article  PubMed  Google Scholar 

  30. Goldberg JI, Wiechmann LI, Riedel ER, Morrow M, Van Zee KJ. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol. 2010;17:3278.

    Article  PubMed  Google Scholar 

  31. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88(3):565–71.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cariati M, Bains SK, Grootendorst MR, Suyoi A, Peters AM, Mortimer P, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. Br J Surg. 2015;102(9):1071–8.

    Article  CAS  PubMed  Google Scholar 

  34. Swaroop MN, Ferguson CM, Horick NK, Skolny MN, Miller CL, Jammallo LS, et al. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort. Breast Cancer Res Treat. 2015;151(2):393–403.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959–72.

    Article  PubMed  Google Scholar 

  36. Helyer LK, Varnic M, Le LW, Leong W, McCready D. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J. 2009;16:1–7.

    Google Scholar 

  37. Stanton AW, Modi S, Bennett Britton TM, Purushotham AD, Peters AM, Levick JR, et al. Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat. 2009;117:549–57.

    Article  PubMed  Google Scholar 

  38. Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res Off J Am Assoc Cancer Res. 2012;18(8):2382–90.

    Article  CAS  Google Scholar 

  39. Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, et al. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol. 2008;6(2):65–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, et al. Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol. 2014;12(1):10–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Newman B, Lose F, Kedda MA, Francois M, Ferguson K, Janda M, et al. Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol. 2012;10(1):2–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Sciences, University of Sydney, Sydney, Australia

    Sharon L. Kilbreath

  2. University of Sydney, Sydney, Australia

    Elizabeth S. Dylke

Authors
  1. Sharon L. Kilbreath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth S. Dylke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharon L. Kilbreath .

Editor information

Editors and Affiliations

  1. Center for the Lymphedema and Vascular Malformations, Division of Vascular Surgery, Department of Surgery, George Washington University, Washington, DC, USA

    Byung-Boong Lee

  2. Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California, USA

    Stanley G. Rockson

  3. La Jolla, California, USA

    John Bergan

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Kilbreath, S.L., Dylke, E.S. (2018). Breast Cancer. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_69

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52423-8_69

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52421-4

  • Online ISBN: 978-3-319-52423-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation